Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

J&J Sues Boehringer Unit Over Doxil Production Pact
Bloomberg
Fri, 09/13/13 - 08:32 am
Tags:
JNJ, Boehringer Ingelheim, Doxil
Conflicting Data on Spiriva Safety
Med Page Today
Wed, 09/11/13 - 08:57 am
Tags:
Spiriva, Boehringer Ingelheim, COPD
J&J Sues Boehringer Ingelheim Over Arbitration Dispute
Bloomberg
Tue, 09/10/13 - 10:21 am
Tags:
JNJ, Boehringer Ingelheim
Boehringer targets sales reps in new round of French job cuts
Fierce Pharma
Mon, 09/9/13 - 10:25 am
Tags:
Boehringer Ingelheim, layoffs, France
Disappointing Results with Boehringer's Pradaxa for Mechanical Valves
Forbes
Tue, 09/3/13 - 09:28 am
Tags:
Pradaxa, mechanical valves, Boehringer Ingelheim, dabigatran
Boehringer sales flat as world pharma market 'stagnates'
Pharma Times, UK
Thu, 08/15/13 - 10:46 am
Tags:
Boehringer Ingelheim, earnings
First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes
Yahoo/PR Newswire
Wed, 07/31/13 - 09:11 am
Tags:
Tradjenta, diabetes, type 2 diabetes, Boehringer Ingelheim, Eli Lilly
3 Potential Game Changers for COPD
Motley Fool
Wed, 07/17/13 - 10:59 am
Tags:
COPD, Anoro, GSK, Theravance, QVA149, Novartis, olodaterol, Boehringer Ingelheim, Pfizer
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
Tags:
non-small cell lung cancer, Gilotrif, Afatinib, Boehringer Ingelheim
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Mon, 07/8/13 - 09:43 am
Tags:
diabetes, Eli Lilly, Boehringer Ingelheim, Europe, LY2963016, long-acting insulin, biosimilars
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Mon, 06/24/13 - 10:31 am
Tags:
Bayer, Boehringer Ingelheim, anticoagulants, Pradaxa, deep vein thrombosis, pulmonary embolism
Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:20 am
Tags:
empagliflozin, type 2 diabetes, diabetes, Boehringer Ingelheim
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
Tags:
FDA, diabetes, Merck, Januvia, Onglyza, Bristol-Myers Squibb, Byetta, AstraZeneca, Eli Lilly, Novo Nordisk, Victoza, Tradjenta, Boehringer Ingelheim
Boehringer to build biopharma facility in China
Pharma Times, UK
Fri, 06/7/13 - 09:45 am
Tags:
China, Boehringer Ingelheim
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
Tags:
physicians, diabetes, Bristol-Myers Squibb, Byetta, Merck, AstraZeneca, Januvia, Novo Nordisk, Eli Lilly, Takeda, Boehringer Ingelheim
J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer
Forbes
Thu, 05/23/13 - 10:44 am
Tags:
JNJ, Medivation, Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, Xarelto, Zytiga
A Boehringer Shake Up And An FDA Warning Letter Over Production Gaffes
Pharmalot
Wed, 05/22/13 - 10:19 am
Tags:
FDA, warnings, Boehringer Ingelheim, drug manufacturing
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wed, 04/24/13 - 08:47 am
Tags:
anticoagulants, Boehringer Ingelheim, Pradaxa
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thu, 04/18/13 - 10:43 am
Tags:
adverse events, diabetes, FDA, Novo Nordisk, Bristol-Myers Squibb, Boehringer Ingelheim, Merck, Eli Lilly
Boehringer Ingelheim fuels gene therapy startup focused on eye diseases
Fierce Biotech
Fri, 04/12/13 - 01:49 pm
Tags:
Boehringer Ingelheim, gene therapy, Eyevensys, Boehringer Ingelheim Venture Fund

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.